SEQURE DX
SeQure DX is in the business activities at non-commercial site business. It was founded in 2020 and is based in Waltham, Massachusetts.
SEQURE DX
Social Links:
Industry:
Commercial
Founded:
2020-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.sequre-dx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
17.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
Aircastle
Aircastle is a company that acquires, leases and sells high-utility commercial jet aircraft to customers worldwide.
bcWORKSHOP
Bcworkshop is in the business activities at non commercial site business.
LuxCreo
LuxCreo is a 3D printing manufacturer
Marlowe Plc
Marlowe Plc focuses to acquire and develop businesses in the outsourced business service sector.
Phillips Edison & Company
Phillips Edison & Company is an internally-managed real estate investment trust (REIT).
reThought Insurance
reThought is a technology-centric MGA focused on product innovation for Commercial Lines.
TPG RE Finance Trust
TRTX is a commercial real estate finance company .
Current Employees Featured
Founder
Investors List
KdT Ventures
KdT Ventures investment in Series A - SeQure DX
Digitalis Ventures
Digitalis Ventures investment in Series A - SeQure DX
Mass General Brigham Ventures
Mass General Brigham Ventures investment in Series A - SeQure DX
Bold Capital Partners
Bold Capital Partners investment in Series A - SeQure DX
Casdin Capital
Casdin Capital investment in Series A - SeQure DX
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - SeQure DX
RiverVest
RiverVest investment in Series A - SeQure DX
Official Site Inspections
http://www.sequre-dx.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.43 K
- Host name: vps32967.dreamhostps.com
- IP address: 67.205.17.97
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "SeQure DX"
SeQure Dx | Risk Assessment for Safe Gene Editing
SeQure Dx specializes in off-target analysis services to reduce risk and improve the safety profile of gene-edited cell and gene therapies. Our advanced assays ensure precise editing …See details»
SeQure Dx - Crunchbase Company Profile & Funding
When was the last funding round for SeQure Dx? SeQure Dx closed its last funding round on Apr 2, 2021 from a Series A round. Who are SeQure Dx 's competitors? Alternatives and possible …See details»
SeQure DX 2025 Company Profile: Valuation, Investors ... - PitchBook
Alexandria Venture Investments, BOLD Capital Partners, Casdin Capital, Digitalis Ventures, and KdT Ventures are 5 of 7 investors who have invested in SeQure DX. Who are SeQure DX’s …See details»
MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering …
Jan 30, 2025 About SeQure Dx SeQure Dx is a leader in gene editing safety analytics, dedicated to advancing cell and gene therapies from discovery to patient. With a robust portfolio of …See details»
SeQure Dx - Products, Competitors, Financials, Employees, …
SeQure Dx specializes in assays that deliver precise editing confirmation and risk assessment for off-target effects, applicable across a wide range of viral and non-viral gene editing modalities. …See details»
Integrated DNA Technologies Announces New Licensing …
Jul 15, 2024 SeQure Dx is a genomics intelligence company dedicated to the advancement of gene editing and cell therapies from discovery to patient. SeQure’s initial preclinical platforms …See details»
MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering …
Jan 30, 2025 MaxCyte notes that SeQure transitioned their primary business activities from an assay development and licensing organization to a contract service provider in March of 2024. …See details»
MaxCyte® Acquires SeQure Dx to Broaden Cell ... - Markets Insider
Jan 30, 2025 SeQure Dx specializes in assays that deliver precise editing confirmation and risk assessment for off-target effects, applicable across a wide range of viral and non-viral gene …See details»
MaxCyte® Acquires SeQure Dx - London Stock Exchange
Jan 29, 2025 SeQure Dx specializes in assays that deliver precise editing confirmation and risk assessment for off-target effects, applicable across a wide range of viral and non-viral gene …See details»
MaxCyte acquires SeQure Dx for $4.5M at closing, sees accretion
Jan 30, 2025 Under the terms of the agreement, Maxcyte paid a total initial consideration of $4.5M at closing in cash for the entire issued share capital of SeQure DX on a cash free, debt …See details»
MaxCyte Acquires SeQure Dx | citybiz
Jan 30, 2025 About SeQure Dx SeQure Dx is a leader in gene editing safety analytics, dedicated to advancing cell and gene therapies from discovery to patient. With a robust portfolio of …See details»
MaxCyte, Inc. Acquires SeQure Dx to Enhance Cell and Gene …
Jan 30, 2025 About SeQure Dx SeQure Dx is a leader in gene editing safety analytics, dedicated to advancing cell and gene therapies from discovery to patient. With a robust portfolio of …See details»
SeQure Dx - Contacts, Employees, Board Members, Advisors
SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, powered …See details»
SeQure Dx emerges from stealth mode to fulfill the promise of on …
Building on Dr. J. Keith Joung’s ONE-seq platform, SeQure Dx has developed a portfolio of assays and data solutions to find, assess, and manage off-target risks from discovery to …See details»
SeQure Dx Announces $17.5M Series A Funding
Patented technology addresses emerging need for personalized diagnostics that assess the risks of gene-editing therapies. WALTHAM, Mass.–(BUSINESS WIRE)–SeQure Dx, a gene-editing …See details»
MaxCyte, Inc. Acquires SeQure Dx to Enhance Cell and Gene
Jan 30, 2025 SeQure Dx reported a loss of approximately $6.5 million in the most recent year, which raises concerns about the financial health of the acquired company and its potential …See details»
SeQure Dx History - maxcyte.com
Founded in 2020, SeQure Dx is dedicated to advancing safety and precision in gene editing through its comprehensive suite of gene-editing selection and risk assessment assays. …See details»
IDT Announces New Licensing Agreement with SeQure Dx to …
Jul 15, 2024 The licensing agreement with SeQure Dx expands IDT’s comprehensive off-target analysis capabilities by providing the company access to SeQure Dx’s next generation …See details»
SeQure Dx | SAFER Detection - maxcyte.com
SeQure Dx's SAFER Detection assay confirms on-target, off-target and homology-mediated structural rearrangements resulting from gene editing. It also profiles integration sites and …See details»
MaxCyte® acquires SeQure Dx to broaden cell engineering …
Feb 6, 2025 MaxCyte notes that SeQure transitioned their primary business activities from an assay development and licensing organization to a contract service provider in March of 2024.See details»